nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Peptic ulcer—Aminophylline—chronic obstructive pulmonary disease	0.0233	0.0308	CcSEcCtD
Phentolamine—Injection site pain—Formoterol—chronic obstructive pulmonary disease	0.0145	0.0192	CcSEcCtD
Phentolamine—Injection site pain—Arformoterol—chronic obstructive pulmonary disease	0.0145	0.0192	CcSEcCtD
Phentolamine—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.0119	0.0157	CcSEcCtD
Phentolamine—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.0119	0.0157	CcSEcCtD
Phentolamine—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.0112	0.0148	CcSEcCtD
Phentolamine—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.0109	0.0144	CcSEcCtD
Phentolamine—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.0106	0.014	CcSEcCtD
Phentolamine—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.0103	0.0136	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisolone—chronic obstructive pulmonary disease	0.00961	0.0127	CcSEcCtD
Phentolamine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00945	0.0125	CcSEcCtD
Phentolamine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00945	0.0125	CcSEcCtD
Phentolamine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.00898	0.0119	CcSEcCtD
Phentolamine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00892	0.0118	CcSEcCtD
Phentolamine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00817	0.0108	CcSEcCtD
Phentolamine—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00742	0.00981	CcSEcCtD
Phentolamine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00726	0.00959	CcSEcCtD
Phentolamine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00725	0.00957	CcSEcCtD
Phentolamine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00725	0.00957	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.0072	0.00951	CcSEcCtD
Phentolamine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00699	0.00923	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.00698	0.00922	CcSEcCtD
Phentolamine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00684	0.00904	CcSEcCtD
Phentolamine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00681	0.009	CcSEcCtD
Phentolamine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00669	0.00884	CcSEcCtD
Phentolamine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00665	0.00878	CcSEcCtD
Phentolamine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00659	0.00871	CcSEcCtD
Phentolamine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00659	0.00871	CcSEcCtD
Phentolamine—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00654	0.00864	CcSEcCtD
Phentolamine—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00654	0.00864	CcSEcCtD
Phentolamine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.0065	0.00859	CcSEcCtD
Phentolamine—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.0065	0.00859	CcSEcCtD
Phentolamine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00598	0.0079	CcSEcCtD
Phentolamine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0057	0.00753	CcSEcCtD
Phentolamine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00554	0.00733	CcSEcCtD
Phentolamine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00553	0.0073	CcSEcCtD
Phentolamine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00553	0.0073	CcSEcCtD
Phentolamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00551	0.00728	CcSEcCtD
Phentolamine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00547	0.00722	CcSEcCtD
Phentolamine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00545	0.0072	CcSEcCtD
Phentolamine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00542	0.00717	CcSEcCtD
Phentolamine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00541	0.00715	CcSEcCtD
Phentolamine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00537	0.00709	CcSEcCtD
Phentolamine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00537	0.00709	CcSEcCtD
Phentolamine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00532	0.00703	CcSEcCtD
Phentolamine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00532	0.00703	CcSEcCtD
Phentolamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0053	0.007	CcSEcCtD
Phentolamine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00526	0.00694	CcSEcCtD
Phentolamine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00522	0.0069	CcSEcCtD
Phentolamine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00522	0.00689	CcSEcCtD
Phentolamine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00522	0.00689	CcSEcCtD
Phentolamine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00519	0.00686	CcSEcCtD
Phentolamine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00514	0.00679	CcSEcCtD
Phentolamine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00512	0.00676	CcSEcCtD
Phentolamine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.0051	0.00674	CcSEcCtD
Phentolamine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00507	0.00669	CcSEcCtD
Phentolamine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00502	0.00664	CcSEcCtD
Phentolamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00495	0.00654	CcSEcCtD
Phentolamine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00471	0.00622	CcSEcCtD
Phentolamine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00454	0.006	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00452	0.00598	CcSEcCtD
Phentolamine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00447	0.00591	CcSEcCtD
Phentolamine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00447	0.00591	CcSEcCtD
Phentolamine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00441	0.00583	CcSEcCtD
Phentolamine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00441	0.00583	CcSEcCtD
Phentolamine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00439	0.00581	CcSEcCtD
Phentolamine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00429	0.00566	CcSEcCtD
Phentolamine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00423	0.00558	CcSEcCtD
Phentolamine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00417	0.0055	CcSEcCtD
Phentolamine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00415	0.00548	CcSEcCtD
Phentolamine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00415	0.00548	CcSEcCtD
Phentolamine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00414	0.00547	CcSEcCtD
Phentolamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00413	0.00545	CcSEcCtD
Phentolamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00413	0.00545	CcSEcCtD
Phentolamine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00406	0.00537	CcSEcCtD
Phentolamine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00395	0.00522	CcSEcCtD
Phentolamine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00395	0.00522	CcSEcCtD
Phentolamine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00393	0.0052	CcSEcCtD
Phentolamine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00392	0.00518	CcSEcCtD
Phentolamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.0039	0.00515	CcSEcCtD
Phentolamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0038	0.00502	CcSEcCtD
Phentolamine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00373	0.00493	CcSEcCtD
Phentolamine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00372	0.00492	CcSEcCtD
Phentolamine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00371	0.0049	CcSEcCtD
Phentolamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00368	0.00486	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00365	0.00483	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00365	0.00483	CcSEcCtD
Phentolamine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00362	0.00478	CcSEcCtD
Phentolamine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00362	0.00478	CcSEcCtD
Phentolamine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00359	0.00474	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00358	0.00473	CcSEcCtD
Phentolamine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00354	0.00468	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00354	0.00468	CcSEcCtD
Phentolamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00353	0.00467	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00352	0.00465	CcSEcCtD
Phentolamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00348	0.0046	CcSEcCtD
Phentolamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00347	0.00458	CcSEcCtD
Phentolamine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00346	0.00457	CcSEcCtD
Phentolamine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00346	0.00457	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00345	0.00456	CcSEcCtD
Phentolamine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00342	0.00451	CcSEcCtD
Phentolamine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00339	0.00448	CcSEcCtD
Phentolamine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00334	0.00442	CcSEcCtD
Phentolamine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00334	0.00442	CcSEcCtD
Phentolamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00333	0.0044	CcSEcCtD
Phentolamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0033	0.00436	CcSEcCtD
Phentolamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00328	0.00434	CcSEcCtD
Phentolamine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00328	0.00434	CcSEcCtD
Phentolamine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00328	0.00433	CcSEcCtD
Phentolamine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00327	0.00432	CcSEcCtD
Phentolamine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00316	0.00417	CcSEcCtD
Phentolamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00311	0.00411	CcSEcCtD
Phentolamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00303	0.00401	CcSEcCtD
Phentolamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00303	0.00401	CcSEcCtD
Phentolamine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00299	0.00395	CcSEcCtD
Phentolamine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00299	0.00395	CcSEcCtD
Phentolamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00297	0.00393	CcSEcCtD
Phentolamine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00293	0.00387	CcSEcCtD
Phentolamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00289	0.00382	CcSEcCtD
Phentolamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00289	0.00382	CcSEcCtD
Phentolamine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00288	0.00381	CcSEcCtD
Phentolamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00287	0.00379	CcSEcCtD
Phentolamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00283	0.00375	CcSEcCtD
Phentolamine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00283	0.00373	CcSEcCtD
Phentolamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0028	0.0037	CcSEcCtD
Phentolamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0028	0.0037	CcSEcCtD
Phentolamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00362	CcSEcCtD
Phentolamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.00361	CcSEcCtD
Phentolamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00269	0.00355	CcSEcCtD
Phentolamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00269	0.00355	CcSEcCtD
Phentolamine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00265	0.0035	CcSEcCtD
Phentolamine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00265	0.0035	CcSEcCtD
Phentolamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00349	CcSEcCtD
Phentolamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00263	0.00348	CcSEcCtD
Phentolamine—Headache—Montelukast—chronic obstructive pulmonary disease	0.0026	0.00343	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00257	0.0034	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00256	0.00338	CcSEcCtD
Phentolamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00336	CcSEcCtD
Phentolamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00251	0.00332	CcSEcCtD
Phentolamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00251	0.00332	CcSEcCtD
Phentolamine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00331	CcSEcCtD
Phentolamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00246	0.00325	CcSEcCtD
Phentolamine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00242	0.0032	CcSEcCtD
Phentolamine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00239	0.00315	CcSEcCtD
Phentolamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.00313	CcSEcCtD
Phentolamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00224	0.00295	CcSEcCtD
Phentolamine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00217	0.00287	CcSEcCtD
Phentolamine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00213	0.00281	CcSEcCtD
Phentolamine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00209	0.00277	CcSEcCtD
Phentolamine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.00272	CcSEcCtD
Phentolamine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00196	0.00259	CcSEcCtD
Phentolamine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00233	CcSEcCtD
Phentolamine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00216	CcSEcCtD
Phentolamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00215	CcSEcCtD
Phentolamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.002	CcSEcCtD
Phentolamine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00149	0.00198	CcSEcCtD
Phentolamine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.0019	CcSEcCtD
Phentolamine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00136	0.0018	CcSEcCtD
Phentolamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00136	0.0018	CcSEcCtD
Phentolamine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00174	CcSEcCtD
Phentolamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00158	CcSEcCtD
Phentolamine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00156	CcSEcCtD
Phentolamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00114	0.0015	CcSEcCtD
Phentolamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00145	CcSEcCtD
Phentolamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00106	0.0014	CcSEcCtD
Phentolamine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00138	CcSEcCtD
Phentolamine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000989	0.00131	CcSEcCtD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00025	0.00103	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	0.000248	0.00102	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000247	0.00101	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000243	0.001	CbGpPWpGaD
Phentolamine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000242	0.000995	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000241	0.000992	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000239	0.000982	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000238	0.000977	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000236	0.000971	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000234	0.000964	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000231	0.000949	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00023	0.000945	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000227	0.000934	CbGpPWpGaD
Phentolamine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000226	0.00093	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000226	0.000927	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000223	0.000917	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000223	0.000915	CbGpPWpGaD
Phentolamine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000222	0.000913	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000221	0.000908	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000219	0.000901	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000215	0.000886	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000215	0.000885	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000213	0.000878	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000213	0.000877	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000211	0.000867	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000211	0.000866	CbGpPWpGaD
Phentolamine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000207	0.000853	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000207	0.000853	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000205	0.000842	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000202	0.000831	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000201	0.000827	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000201	0.000826	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000199	0.000819	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000199	0.000818	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000196	0.000806	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00019	0.000783	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00019	0.000782	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00019	0.000779	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000188	0.000772	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000185	0.00076	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000184	0.000757	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000184	0.000755	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000182	0.00075	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000182	0.000748	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000181	0.000746	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000181	0.000745	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000181	0.000744	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000181	0.000743	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00018	0.000739	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000178	0.000731	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000174	0.000716	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000174	0.000716	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000173	0.000712	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000172	0.000707	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000172	0.000706	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000171	0.000704	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00017	0.000701	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000169	0.000697	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000169	0.000695	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000169	0.000693	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000168	0.00069	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000168	0.00069	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000167	0.000687	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000165	0.000679	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000165	0.000679	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000164	0.000675	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000163	0.000672	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000163	0.000671	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000162	0.000665	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000162	0.000665	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000161	0.00066	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00016	0.00066	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000158	0.00065	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000158	0.00065	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000158	0.000649	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000157	0.000647	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000157	0.000646	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000152	0.000627	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000152	0.000626	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000151	0.00062	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00015	0.000617	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000149	0.000613	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000147	0.000603	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000147	0.000603	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000144	0.000594	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000143	0.000587	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00014	0.000577	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00014	0.000577	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00014	0.000575	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000139	0.000572	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.000571	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000138	0.000569	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000138	0.000566	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000137	0.000565	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000136	0.00056	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000136	0.000558	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000134	0.000551	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000133	0.000548	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000133	0.000548	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000131	0.00054	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000131	0.000539	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00013	0.000536	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00013	0.000536	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000129	0.000532	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000128	0.000528	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000126	0.000517	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000125	0.000513	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000124	0.000509	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000122	0.000503	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000119	0.000491	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000119	0.00049	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000117	0.000483	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000117	0.00048	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000117	0.000479	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000116	0.000479	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000116	0.000476	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000116	0.000475	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000114	0.000471	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000114	0.000469	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.000464	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000109	0.000449	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000108	0.000445	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000108	0.000443	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000108	0.000442	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000107	0.000442	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000107	0.00044	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000107	0.000439	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000106	0.000437	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000103	0.000422	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.000415	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000101	0.000414	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.91e-05	0.000408	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.76e-05	0.000401	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.71e-05	0.000399	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.7e-05	0.000399	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.63e-05	0.000396	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.54e-05	0.000392	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.53e-05	0.000392	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.46e-05	0.000389	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	9.43e-05	0.000388	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.4e-05	0.000387	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.33e-05	0.000384	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.27e-05	0.000381	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.07e-05	0.000373	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9e-05	0.00037	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.92e-05	0.000367	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.86e-05	0.000364	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.86e-05	0.000364	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.81e-05	0.000362	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	8.8e-05	0.000362	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.8e-05	0.000362	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.76e-05	0.00036	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.69e-05	0.000357	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.68e-05	0.000357	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.64e-05	0.000355	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.43e-05	0.000347	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.23e-05	0.000339	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.19e-05	0.000337	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.18e-05	0.000336	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.18e-05	0.000336	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.1e-05	0.000333	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.05e-05	0.000331	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.93e-05	0.000326	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.87e-05	0.000324	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.87e-05	0.000324	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.84e-05	0.000322	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.75e-05	0.000319	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.36e-05	0.000303	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.32e-05	0.000301	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.31e-05	0.000301	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.2e-05	0.000296	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.2e-05	0.000296	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	7.15e-05	0.000294	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.15e-05	0.000294	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.14e-05	0.000293	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.88e-05	0.000283	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	6.86e-05	0.000282	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.81e-05	0.00028	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.69e-05	0.000275	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.64e-05	0.000273	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	6.56e-05	0.00027	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.5e-05	0.000267	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.44e-05	0.000265	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.4e-05	0.000263	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.39e-05	0.000263	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.15e-05	0.000253	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.02e-05	0.000247	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.94e-05	0.000244	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.92e-05	0.000244	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.87e-05	0.000241	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.77e-05	0.000237	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.74e-05	0.000236	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.65e-05	0.000232	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	5.57e-05	0.000229	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.48e-05	0.000226	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.48e-05	0.000225	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.4e-05	0.000222	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.33e-05	0.000219	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.26e-05	0.000216	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.22e-05	0.000215	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.21e-05	0.000214	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.02e-05	0.000206	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.95e-05	0.000204	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.89e-05	0.000201	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.86e-05	0.0002	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.79e-05	0.000197	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.79e-05	0.000197	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.71e-05	0.000194	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.68e-05	0.000193	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.66e-05	0.000192	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.62e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.55e-05	0.000187	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.45e-05	0.000183	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.4e-05	0.000181	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.33e-05	0.000178	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.3e-05	0.000177	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.25e-05	0.000175	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.23e-05	0.000174	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.22e-05	0.000173	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.04e-05	0.000166	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.95e-05	0.000162	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.95e-05	0.000162	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.89e-05	0.00016	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.88e-05	0.00016	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.85e-05	0.000158	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.81e-05	0.000156	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.76e-05	0.000154	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.63e-05	0.000149	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.57e-05	0.000147	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.57e-05	0.000147	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.55e-05	0.000146	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.54e-05	0.000146	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.5e-05	0.000144	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.45e-05	0.000142	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.24e-05	0.000133	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.21e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.2e-05	0.000131	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.17e-05	0.00013	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.11e-05	0.000128	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.98e-05	0.000123	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.94e-05	0.000121	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.94e-05	0.000121	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.92e-05	0.00012	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000119	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.73e-05	0.000112	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.69e-05	0.000111	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.61e-05	0.000107	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.42e-05	9.97e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.39e-05	9.82e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.22e-05	9.13e-05	CbGpPWpGaD
